Benign Prostate Surgery and QOL and Sexual Function

NCT05826691 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2023-04-24

No results posted yet for this study

Summary

Rationale: A variety of surgical techniques have been described for surgical treatment of male LUTS because of BPH, which has different outcomes and may result in adverse events regarding ejaculatory function and erection, resulting in a negative impact on QOL on short- and mid-term follow-ups.

Objective: To compare outcomes of BPH surgery using a conventional versus ejaculation preserving technique on QOL-related aspects with emphasis on ejaculatory and erectile function.

Study design: This study is a prospective longitudinal multi-center trial to compare the ejaculatory and erectile function outcomes between conventional and ejaculation preserving BPH surgical procedures/techniques. Baseline characteristics will be recorded, as well as short and mid-term follow-up.

Study population: The study population comprises patients who will undergo BPH surgery in the participating centers.

Intervention: All patients will undergo BPH surgery (including but not restricted to Monopolar / Bipolar Transurethral resection of the prostate (TURP), photo vaporisation (PVP), Plasmakinetic (PK), Holmium laser enucleation of the prostate (HOLEP) or open prostatectomy (OP)).

Main study parameters/endpoints: Primary endpoint is to compare the baseline to the short-term (3 months) and mid-term (6 months) ejaculation function and QoL outcomes. The secondary endpoint is the short and mid-term erection function and QoL outcomes compared to baseline.

Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Patients' burden and risk associated with participating in this trial do not differ among surgical procedures or techniques used. In all groups, patients will undergo a BPH surgery and will be followed for six months at 3 visits.

Conditions

  • Quality of Life
  • Sexual Dysfunction
  • Ejaculatory Dysfunction
  • Lower Urinary Tract Symptoms
  • Erectile Dysfunction
  • Incontinence

Interventions

PROCEDURE

Monopolar / Bipolar Transurethral resection of prostate (TURP), photovaporisation (PVP), Plasmakinetic (PK), Holmium laser enucleation of the prostate (HOLEP) or open prostatectomy (OP)).

Any procedure advised by the EAU guidelines to ovrecome bladder outlet obstruction

Sponsors & Collaborators

  • TC Erciyes University

    collaborator OTHER
  • Gaziosmanpasa Research and Education Hospital

    collaborator OTHER_GOV
  • Goztepe Training and Research Hospital

    collaborator OTHER
  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

    collaborator OTHER
  • Ankara Education and Research Hospital

    collaborator OTHER_GOV
  • Uludag University

    collaborator OTHER
  • Kırıkkale University

    collaborator OTHER
  • SB Istanbul Education and Research Hospital

    collaborator OTHER
  • Kayseri City Hospital

    collaborator OTHER_GOV
  • Bagcilar Training and Research Hospital

    collaborator OTHER_GOV
  • Ataturk University

    collaborator OTHER
  • Sisli Hamidiye Etfal Training and Research Hospital

    collaborator OTHER
  • Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

    collaborator OTHER
  • Haydarpasa Numune Training and Research Hospital

    collaborator OTHER
  • SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi

    collaborator OTHER
  • Fatih Sultan Mehmet Training and Research Hospital

    collaborator OTHER
  • Firat University

    collaborator OTHER
  • Recep Tayyip Erdogan University

    collaborator OTHER
  • Yuzuncu Yıl University

    collaborator OTHER
  • Ondokuz Mayıs University

    collaborator OTHER
  • Dr. Lutfi Kirdar Kartal Training and Research Hospital

    collaborator OTHER_GOV
  • Ankara City Hospital Bilkent

    collaborator OTHER
  • Izmir Katip Celebi University

    collaborator OTHER
  • Haseki Training and Research Hospital

    collaborator OTHER
  • Istanbul Medipol University Hospital

    lead OTHER

Principal Investigators

  • Johan J de la Rosette, MD PhD · Medipol University

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-06-01
Completion
2023-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05826691 on ClinicalTrials.gov